We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.9646 | -0.75% | 126.8954 | 128.26 | 126.36 | 126.85 | 3,179,139 | 01:00:00 |
From Jul 2023 to Jul 2024
By Cecilia Butini
Swiss medical-devices manufacturer Ypsomed said Wednesday that it will supply Novo Nordisk with a large amount of autoinjectors as part of a long-term supply agreement.
The company said it will deliver 1 million auto-injectors to be used for various drugs, and that it will expand its manufacturing capacities over the coming years as a result.
Third-party manufacturers will also get the right to manufacture as part of a royalty scheme, said Ypsomed.
The supply agreement with the Danish pharma giant, however, won't have any material impact on the outlook for the current financial year, the company said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
September 20, 2023 05:59 ET (09:59 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
